ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1065

Artesunate Can Synergize with Methotrexate on Inhibiting Migration and Invasion of Fibroblast-like Synoviocytes from Patients with Rheumatoid Arthritis

Jian-Da Ma1, Jun Jing1, Jun-Wei Wang1, Tao Yan2, Yun-Shan Mou2, Ying-Qian Mo1 and Lie Dai1, 1Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China, 2Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Fibroblasts, methotrexate (MTX) and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Monday, October 22, 2018

Session Title: Rheumatoid Arthritis – Etiology and Pathogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Fibroblast-like synoviocytes (FLS) play important roles on joint destruction in rheumatoid arthritis (RA). Recent reports showed that antimalaria drug artesunate presents anti-cancer potential by suppressing cancer cells invasion and metastasis. We have found that artesunate could inhibit migration and invasion of RA-FLS as well as MMP-2/9 expression. Methotrexate (MTX) is the anchor drug for RA treatment. Here we aimed to investigate the synergistic effect of artesunate with MTX on inhibiting aggressive ability of RA-FLS.

Methods: Synovial tissues were obtained by closed needle biopsy from 6 active RA patients and FLS were isolated. Primary RA-FLS were cultured in vitro and pretreated with 60¦ÌM artesunate, 10nM MTX, or combination of 60¦ÌM artesunate and 2.5nM~10nM MTX respectively for indicated times. Their effects on cell viability and proliferation were measured by CCK-8 assay, while effects on migration and invasion capacity of RA-FLS were detected by wound healing and transwell assays. Differential expression of MMP-2/9 and tissue inhibitors of metalloproteinases (TIMP) -1/2 were detected by quantitative real-time PCR, western blot and ELISA.

Results: (1) Compared with untreated group, 60¦ÌM artesunate, 10nM MTX or combination of 60¦ÌM artesunate and 2.5nM~10nM MTX showed no significant effect on cell viability and proliferation of RA-FLS for 72 hours (Fig 1A). (2) Both 60¦ÌM artesunate and10nM MTX alone significantly inhibited migration and invasion of RA-FLS. The combination of 60¦ÌM artesunate and 7.5nM MTX had stronger inhibitory effect on migration and invasion than 60¦ÌM artesunate or 10nM MTX alone (Fig 1B). (3) Both 60¦ÌM artesunate and10nM MTX alone significantly inhibited MMP-2/9 expression but promoted the expression of TIMP-2. The combination of 60¦ÌM artesunate and 7.5nM MTX had stronger effect on regulating MMP-9 and TIMP-2 than 60¦ÌM artesunate or 10nM MTX alone (Fig 1C).

Conclusion: Artesunate can synergize with MTX on inhibiting migration and invasion of primary RA-FLS by inhibiting MMP-9 and promoting TIMP-2 expression, which implies the potential of combination therapy of artesunate and MTX for RA.

Fundings: This work was supported by National Natural Science Foundation of China (no. 81471597, 81671612), Guangdong Natural Science Foundation (no. 2017A030313576, 2017A030310236) and Scientific Program of Traditional Chinese Medicine Bureau of Guangdong Province (no. 20161058, 20181058).



Disclosure: J. D. Ma, None; J. Jing, None; J. W. Wang, None; T. Yan, None; Y. S. Mou, None; Y. Q. Mo, None; L. Dai, None.

To cite this abstract in AMA style:

Ma JD, Jing J, Wang JW, Yan T, Mou YS, Mo YQ, Dai L. Artesunate Can Synergize with Methotrexate on Inhibiting Migration and Invasion of Fibroblast-like Synoviocytes from Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10). https://acrabstracts.org/abstract/artesunate-can-synergize-with-methotrexate-on-inhibiting-migration-and-invasion-of-fibroblast-like-synoviocytes-from-patients-with-rheumatoid-arthritis/. Accessed January 27, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/artesunate-can-synergize-with-methotrexate-on-inhibiting-migration-and-invasion-of-fibroblast-like-synoviocytes-from-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.